In addition, in vitro studies, SOX9 expression is suppressed by androgens in ERG-negative prostate cancer cells, therefore ADT may actually induce SOX9 expression in ERG-negative patients [14, 22]. This evidence concerns the gene SOX9 and prostate cancer.